Logos Global Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-66,666
Closed -$22K – 80
2025
Q4
$22K Hold
66,666
– – ﹤0.01% 69
2025
Q3
$13.5K Hold
66,666
– – ﹤0.01% 59
2025
Q2
$18K Hold
66,666
– – ﹤0.01% 51
2025
Q1
$15.9K Hold
66,666
– – ﹤0.01% 39
2024
Q4
$15.3K Buy
+66,666
New +$8.63K ﹤0.01% 47
2024
Q3
– Sell
-66,666
Closed -$10.7K – 64
2024
Q2
$10.7K Hold
66,666
– – ﹤0.01% 57
2024
Q1
$22.7K Hold
66,666
– – ﹤0.01% 57
2023
Q4
$4K Hold
66,666
– – ﹤0.01% 53
2023
Q3
$6.67K Hold
66,666
– – ﹤0.01% 56
2023
Q2
$11K Hold
66,666
– – ﹤0.01% 51
2023
Q1
$8K Hold
66,666
– – ﹤0.01% 43
2022
Q4
$9.63K Hold
66,666
– – ﹤0.01% 40
2022
Q3
$13K Hold
66,666
– – ﹤0.01% 39
2022
Q2
$19K Hold
66,666
– – ﹤0.01% 32
2022
Q1
$54K Hold
66,666
– – 0.01% 47
2021
Q4
$126K Hold
66,666
– – 0.01% 65
2021
Q3
$177K Hold
66,666
– – 0.01% 56
2021
Q2
$173K Hold
66,666
– – 0.01% 57
2021
Q1
$178K Buy
+66,666
New +$193K 0.02% 52

Logos Global Management's NUVB.WS Position: Q1 2026 in Review

Logos Global Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 66,666 shares — an estimated $22K sold.

Logos Global Management first reported a position in NUVB.WS in Q1 2021 and held it in 19 quarters. The position peaked at $178K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.

  • Logos Global Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
  • Logos Global Management sold 66,666 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $22K.
  • Logos Global Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 19 quarters.
  • Logos Global Management's Nuvation Bio Inc Warrants position peaked at $178K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.